Treatment of 1-antitrypsin deficiency is costly

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1284, 2001-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of 1-antitrypsin deficiency is costly

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 309, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The promise of gene therapy for the treatment of αα-1 antitrypsin deficiency

By Cruz Pedro E   Mueller Christian   Flotte Terence R  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1191-1198

Future Medicine

Access to resources Recommend Favorite

Alpha-1 Antitrypsin Deficiency: Treatment Beyond Augmentation Therapy

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 4, 2010-12 ,pp. : 330-335

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha-1-Antitrypsin Deficiency Liver Disease and New Treatment Opportunities

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 5, 1970-01 ,pp. : 382-391

Bentham Science Publishers

Access to resources Recommend Favorite

Augmentation Therapy for 1 -Antitrypsin Deficiency

By Georges S. Juvelekian   James K. Stoller  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1743-1756

Adis International

Access to resources Recommend Favorite